Home    Back

 Drug    DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, Adalimumab

ABCDEFGH I JKLMNOPQRSTUVWXYZother

267 / 17,542 descriptions

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 Disease ID
 1  11c-acetate  Acetate  -  -  -  [3] 13, 86, 88 💬 
 2  20mg/0.5ml glatiramer acetate  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 3  40 mg glatiramer acetate  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [2]  2 , 13 💬 
 4  40 mg glatiramer acetato  Glatiramer  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 5  5% lidocaine/5 mg/ml 0.02% estradiol compound cream  Estradiol  [11] D00105, D00358, D01413, D01617, D01953, D02086, D04061, D04063, D04064, D04065, D08127 💬  [7] ESR1, ESR2, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬  [12] Adrenergic signaling in cardiomyocytes, Breast cancer, Dopaminergic synapse, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Taste transduction, Thyroid hormone signaling pathway  [1] 226 💬 
 6  90 mg hydrocortisone acetate suppository with sephure suppository applicator  Acetate  [2] D00088, D00165 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 97 💬 
 7  [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate  Acetate  [1] D02691 💬  [1] GHR 💬  [5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway  [1] 265 💬 
 8  Abiraterone  Abiraterone  [1] D09701 💬  -  -  [2] 75, 81 💬 
 9  Abiraterone acetate  Abiraterone  [1] D09701 💬  -  -  [2] 75, 81 💬 
 10  Acetate  Acetate  -  -  -  [43]  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 
 11  Administration of rituximab and methylprednisolone  Methylprednisolone  [7] D00407, D00751, D00979, D02994, D05000, D05001, D05002 💬  [2] MS4A1, NR3C1 💬  [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction  [1] 51 💬 
 12  Azd4017 and prednisolone  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 75 💬 
 13  Bazedoxifene  Bazedoxifene  [1] D03062 💬  -  -  [1] 13 💬 
 14  Bazedoxifene acetate  Acetate  [1] D03062 💬  -  -  [1] 13 💬 
 15  Betamethasone  Betamethasone  [7] D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [6]  2 , 28, 46, 90, 96, 235 💬 
 16  Betamethasone acibutate  Betamethasone  [7] D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 17  Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days  Acetate  [7] D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1]  2  💬 
 18  Bortezomib/dexamethasone  Bortezomib  [10] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬  [2] NR3C1, PSMB5 💬  [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia  [1] 283 💬 
 19  Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone  Bortezomib  [10] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150 💬  [2] NR3C1, PSMB5 💬  [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia  [1] 28 💬 
 20  Bupivacaine/epinephrine/dexamethasone  Bupivacaine  [14] D00095, D00292, D00975, D00996, D01450, D01510, D01615, D01632, D01948, D02149, D02174, D02591, D02592, D07552 💬  [15] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬  [15] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 96 💬 
 21  Caspofungin  Caspofungin  [2] D02501, D07626 💬  -  -  [1] 60 💬 
 22  Caspofungin acetate  Acetate  [2] D02501, D07626 💬  -  -  [1] 60 💬 
 23  Cetrorelix  Cetrorelix  [2] D01685, D07665 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 46 💬 
 24  Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine  Azathioprine  [12] D00238, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994, D03033 💬  [2] MS4A1, NR3C1 💬  [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction  [1] 35 💬 
 25  Combination product: twice daily 90 mg hydrocortisone acetate suppository administered with sephure applicator  Acetate  [2] D00088, D00165 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 97 💬 
 26  Combination therapy with vigabatrin and prednisolone  Prednisolone  [9] D00472, D00535, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [2] ABAT, NR3C1 💬  [8] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism  [1] 145 💬 
 27  Control intervention (no dexamethasone)  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 28  Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)  Acetate  [21] D00088, D00292, D00472, D00473, D00973, D00975, D00980, D00981, D00982, D01239, D01510, D01615, D01632, D01948, D01998, D02156, D02174, D02591, D02592, D03301, D07749 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 29  Corticosteroid (prednisolone)  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 85 💬 
 30  Corticosteroid treatment (methylprednisolone or prednisolone)  Methylprednisolone  [14] D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 64 💬 
 31  Corticosteroids (prednisone or prednisolone)  Prednisolone  [9] D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 49 💬 
 32  Cortisone acetate  Acetate  [2] D00973, D07749 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 33  Cosyntropin acetate  Acetate  [1] D00284 💬  [1] MC2R 💬  [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway  [1] 113 💬 
 34  Cyclophosphamide, azathioprine,prednisone,methylprednisolone  Azathioprine  [11] D00238, D00287, D00407, D00473, D00751, D00979, D03033, D05000, D05001, D05002, D07760 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [3] 42, 43, 45 💬 
 35  Cyclophosphamide, bortezomib, and dexamethasone (cybord)  Bortezomib  [12] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬  [2] NR3C1, PSMB5 💬  [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia  [1] 28 💬 
 36  Cyclophosphamide, bortezomib, dexamethasone  Bortezomib  [12] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760 💬  [2] NR3C1, PSMB5 💬  [9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia  [1] 28 💬 
 37  Cyclophosphamide, bortezomib, dexamethasone plus daratumumab  Bortezomib  [13] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D03150, D07760, D10777 💬  [3] CD38, NR3C1, PSMB5 💬  [16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia  [1] 28 💬 
 38  Cyclophosphamide/glatiramer acetate  Acetate  [3] D00287, D04318, D07760 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 39  Ddavp (desmopressin)  Desmopressin  [2] D00291, D02235 💬  [2] AVPR2, F8 💬  [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption  [1] 288 💬 
 40  Delmitide acetate  Acetate  -  -  -  [1] 97 💬 
 41  Depot leuprolide acetate 3.75 mg  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 51 💬 
 42  Desmopressin  Desmopressin  [2] D00291, D02235 💬  [2] AVPR2, F8 💬  [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption  [5]  6 , 64, 72, 225, 288 💬 
 43  Desmopressin acetat  Desmopressin  [2] D00291, D02235 💬  [2] AVPR2, F8 💬  [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption  [1]  6  💬 
 44  Desmopressin acetate  Acetate  [2] D00291, D02235 💬  [2] AVPR2, F8 💬  [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption  [2] 64, 288 💬 
 45  Desmopressin acetate trihydrate  Acetate  [2] D00291, D02235 💬  [2] AVPR2, F8 💬  [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption  [1] 225 💬 
 46  Desmopressin intranasal  Desmopressin  [2] D00291, D02235 💬  [2] AVPR2, F8 💬  [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption  [1] 72 💬 
 47  Desmopressin oral melt  Desmopressin  [2] D00291, D02235 💬  [2] AVPR2, F8 💬  [4] Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption  [1] 72 💬 
 48  Device: cellulose acetate with petrolatum  Acetate  [3] D00093, D05304, D05331 💬  -  -  [2] 35, 162 💬 
 49  Device: dexamethasone injection  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 90 💬 
 50  Dexamethasone  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 
 51  Dexamethasone (1 cycle)  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 63 💬 
 52  Dexamethasone (4 cycles)  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 63 💬 
 53  Dexamethasone (50mg 1dd6, 3 consecutive days/month)  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 35 💬 
 54  Dexamethasone 0,1 mg tablets  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 55  Dexamethasone 0,5mg  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 84 💬 
 56  Dexamethasone 0.5mg tablet  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 57  Dexamethasone 0.5mg/5ml solution  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [2] 35, 162 💬 
 58  Dexamethasone 0.5mg/5ml solution in mucolox™  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [2] 35, 162 💬 
 59  Dexamethasone 1,5 mg tablets  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 60  Dexamethasone 21-dihydrogen phosphate  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 65 💬 
 61  Dexamethasone 21-phosphate  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 97 💬 
 62  Dexamethasone 2mg tablets  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 63  Dexamethasone 4 mg jenapharm  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 28 💬 
 64  Dexamethasone abcur  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 63 💬 
 65  Dexamethasone and rituximab  Dexamethasone  [10] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D02994 💬  [2] MS4A1, NR3C1 💬  [2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction  [1] 63 💬 
 66  Dexamethasone oral tablet 8mg (dexamethasone krka tablets(8mg), warsaw, poland).  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 235 💬 
 67  Dexamethasone parotid irrigation  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 53 💬 
 68  Dexamethasone sodium phosphate  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [3] 65, 70, 96 💬 
 69  Dexamethasone sodium phosphate 250 mg/ 10 ml  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 96 💬 
 70  Dexamethasone sodium phosphate 250 mg/10 ml solution  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 299 💬 
 71  Dexamethasone sodium phosphate ph. eur.  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 65 💬 
 72  Dexamethasone sodium sulfate  Dexamethasone  [11] D00292, D00975, D01510, D01615, D01632, D01732, D01948, D02174, D02591, D02592, D05877 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 28 💬 
 73  Dexamethasone soduim phosphate  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 13 💬 
 74  Dexamethasone, 40 mg  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 28 💬 
 75  Diagnostic test: dexamethasone test  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 75 💬 
 76  Dirucotide acetate  Acetate  [1] D09396 💬  -  -  [1] 13 💬 
 77  Edratide acetate  Acetate  [1] D03957 💬  -  -  [1] 49 💬 
 78  Estradiol  Estradiol  [8] D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬  [2] ESR1, ESR2 💬  [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway  [5] 13, 46, 49, 226, 299 💬 
 79  Estradiol 2 mg  Estradiol  [8] D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬  [2] ESR1, ESR2 💬  [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway  [1] 299 💬 
 80  Estradiol hemihydrate  Estradiol  [8] D00105, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬  [2] ESR1, ESR2 💬  [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway  [1] 13 💬 
 81  Etanercept, methotrexate, prednisolone  Etanercept  [11] D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬  [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬  [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway  [1] 56 💬 
 82  Ethinyl estradiol  Estradiol  [9] D00105, D00554, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬  [2] ESR1, ESR2 💬  [9] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway  [3] 46, 49, 299 💬 
 83  Experimental glatiramer acetate  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 84  Flecainide  Flecainide  [2] D00638, D07962 💬  [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬  [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction  [1]  6  💬 
 85  Flecainide acetate  Acetate  [2] D00638, D07962 💬  [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬  [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction  [1]  6  💬 
 86  Fludrocortisone  Fludrocortisone  [2] D00986, D07967 💬  [1] NR3C2 💬  [1] Aldosterone-regulated sodium reabsorption  [3]  6 , 17, 81 💬 
 87  Gallium-68-dota-n-octreotide  Octreotide  [2] D00442, D06495 💬  [1] SSTR2 💬  [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway  [1] 84 💬 
 88  Glatiramer  Glatiramer  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [4]  2 , 13, 96, 156 💬 
 89  Glatiramer acetate  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [3] 13, 96, 156 💬 
 90  Glatiramer acetate (copaxone®)  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [2] 13, 156 💬 
 91  Glatiramer acetate (db)  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 92  Glatiramer acetate (ga)  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 93  Glatiramer acetate (ga) 40 mg  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 94  Glatiramer acetate (gtr)  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 95  Glatiramer acetate (ol)  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 96  Glatiramer acetate 150mg enteric coated tablets  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 97  Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 98  Glatiramer acetate 20 mg  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 99  Glatiramer acetate 20 mg, with mitoxantrone  Acetate  [3] D02166, D04318, D08224 💬  [22] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TOP2A, TOP2B 💬  [33] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 100  Glatiramer acetate 20 mg/0.5 ml  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 101  Glatiramer acetate 40 mg  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 102  Glatiramer acetate [ga]  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 103  Glatiramer acetate injection with oral cetirizine hydrochloride  Acetate  [3] D00664, D04318, D07662 💬  [21] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, HRH1 💬  [35] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Calcium signaling pathway, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 104  Glatiramer acetate with minocycline  Acetate  [3] D00850, D04318, D05045 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 105  Glatiramer acetate, (copaxone®)  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 106  Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 107  Glatiramer acetate, n-acetylcysteine  Acetate  [2] D00221, D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 108  Glatiramer acetato  Glatiramer  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 109  Glucocorticoid (prednisone or prednisolone)  Prednisolone  [9] D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 84 💬 
 110  Gonadorelin  Gonadorelin  [4] D00988, D03267, D04361, D08027 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 111  Gonadorelin acetate and triptorelin acetate  Acetate  [5] D00988, D03267, D04361, D06247, D08027 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 112  Goserelin  Goserelin  [2] D00573, D04405 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1]  1  💬 
 113  Hematide, peginesatide  Peginesatide  [2] D09946, D09947 💬  [1] EPOR 💬  [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer  [1] 283 💬 
 114  High dose dexamethasone pulses  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 63 💬 
 115  Human interferon beta-1a and glatiramer acetate  Acetate  [2] D04318, D04554 💬  [22] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, IFNAR1, IFNAR2 💬  [44] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 116  Hydrocortisone acetate  Acetate  [2] D00088, D00165 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 97 💬 
 117  Hydrocortisone sodium acetate  Acetate  [2] D00088, D01779 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 118  Hydroxocobalamin  Hydroxocobalamin  [3] D01027, D02707, D04929 💬  -  -  [1] 97 💬 
 119  Hydroxocobalamin with butyrate  Butyric Acid  [4] D01027, D02707, D04929, D05866 💬  -  -  [1] 97 💬 
 120  Infliximab, methylprednisolone, methotrexate  Infliximab  [9] D00142, D00407, D00751, D00979, D02115, D02598, D05000, D05001, D05002 💬  [4] DHFR, DHFR2, NR3C1, TNF 💬  [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway  [1] 46 💬 
 121  Interferon-beta-1a (avonex) plus methylprednisolone  Human interferon beta  [7] D00407, D00751, D00979, D04554, D05000, D05001, D05002 💬  [3] IFNAR1, IFNAR2, NR3C1 💬  [19] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway  [1] 13 💬 
 122  Intra-articular compound betamethasone  Betamethasone  [7] D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 123  Intraarticular betamethasone  Betamethasone  [7] D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 124  Intraarticular dexamethasone  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 125  Intravenous (i.v.) methylprednisolone 1000 mg, total 9  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 222 💬 
 126  Intravenous dexamethasone 1 mg  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 127  Intravenous methyl prednisolone  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 43 💬 
 128  Intravenous methylprednisolone  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [2] 13, 145 💬 
 129  Iv methylprednisolone  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 13 💬 
 130  Iv methylprednisolone (steroids)  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 13 💬 
 131  L-lysyl-d-prolyl-l-threonine acetate  Acetate  [1] D00041 💬  -  -  [1] 97 💬 
 132  L-lysyl-d-prolyl-lthreonine acetate, lyophilisate  Acetate  -  -  -  [1] 97 💬 
 133  Lanreotide  Lanreotide  [1] D04666 💬  -  -  [4] 67, 73, 85, 298 💬 
 134  Lanreotide acetate  Acetate  [1] D04666 💬  -  -  [4] 67, 73, 85, 298 💬 
 135  Lapaquistat acetate and current lipid-lowering treatment  Acetate  -  -  -  [1] 79 💬 
 136  Lenalidomide and dexamethasone  Dexamethasone  [10] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬  [2] NR3C1, TNF 💬  [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway  [1] 16 💬 
 137  Lenalidomide+dexamethasone  Dexamethasone  [10] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬  [2] NR3C1, TNF 💬  [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway  [1] 16 💬 
 138  Lenalidomide, dexamethasone  Dexamethasone  [10] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687 💬  [2] NR3C1, TNF 💬  [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway  [1] 16 💬 
 139  Lenalidomide, dexamethasone and cyclophosphamide  Cyclophosphamide  [12] D00287, D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D04687, D07760 💬  [2] NR3C1, TNF 💬  [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway  [1] 28 💬 
 140  Leuprolide  Leuprolide  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [5]  1 ,  2 ,  3 , 51, 76 💬 
 141  Leuprolide (gnrh agonists)  Gonadorelin  [6] D00988, D00989, D03267, D04361, D08027, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 142  Leuprolide acetate (la)  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 143  Leuprolide acetate 11.25 mg  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 144  Leuprolide acetate 3 month depot  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 145  Leuprolide acetate 30 mg  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 146  Leuprolide acetate 45 mg  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 147  Leuprolide acetate depot  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 148  Leuprorelin acetate  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [2]  1 , 76 💬 
 149  Leuprorelin acetate 3.75mg injection  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 150  Lodotra (delayed release prednisolone)  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 41 💬 
 151  Loestrin (norethindrone acetate and ethinyl estradiol)  Acetate  [11] D00105, D00182, D00554, D00953, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬  [3] ESR1, ESR2, PGR 💬  [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway  [1] 299 💬 
 152  Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol)  Acetate  [11] D00105, D00182, D00554, D00953, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬  [3] ESR1, ESR2, PGR 💬  [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway  [2] 46, 49 💬 
 153  Long-circulating liposomal prednisolone  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 154  Low dose prednisolone  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 84 💬 
 155  Luphere depot 3.75mg(leuprolide acetate 3.75mg)  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 156  Lupron (leuprolide acetate)  Acetate  [2] D00989, D08113 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 157  Macimorelin acetate  Acetate  [1] D10563 💬  [1] GHSR 💬  [3] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway  [1] 78 💬 
 158  Medium dose prednisolone  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 84 💬 
 159  Megadose oral methylprednisolone  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 13 💬 
 160  Megestrol acetate  Acetate  [2] D00952, D08167 💬  [1] PGR 💬  [4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation  [1] 76 💬 
 161  Megestrol acetate tablet  Acetate  [2] D00952, D08167 💬  [1] PGR 💬  [4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation  [1] 76 💬 
 162  Melphalan, thalidomide and dexamethasone  Dexamethasone  [11] D00292, D00369, D00754, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [2] NR3C1, TNF 💬  [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway  [1] 28 💬 
 163  Methotrexate + methylprednisolone  Methotrexate  [8] D00142, D00407, D00751, D00979, D02115, D05000, D05001, D05002 💬  [3] DHFR, DHFR2, NR3C1 💬  [6] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate  [1] 46 💬 
 164  Methotrexate - etanercept - prednisolone arm  Etanercept  [11] D00142, D00472, D00742, D00980, D00981, D00982, D01239, D01998, D02115, D02156, D03301 💬  [5] DHFR, DHFR2, LTA, NR3C1, TNF 💬  [70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway  [1] 46 💬 
 165  Methyl prednisolone  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [3] 43, 49, 96 💬 
 166  Methylprednisolone  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [44]  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 
 167  Methylprednisolone (drug)  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 13 💬 
 168  Methylprednisolone (mp)  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [2] 60, 285 💬 
 169  Methylprednisolone (mp) or prednisone (pred)  Methylprednisolone  [7] D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 66 💬 
 170  Methylprednisolone (or other glucocorticoid)  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 43 💬 
 171  Methylprednisolone (solu-medrol)  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 14 💬 
 172  Methylprednisolone 1250 mg/24h x3 days  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 13 💬 
 173  Methylprednisolone acetate  Acetate  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 51 💬 
 174  Methylprednisolone bolus iv 15 mg/kg/d for 3 days.  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 84 💬 
 175  Methylprednisolone hemisuccinate  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 13 💬 
 176  Methylprednisolone iv  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 13 💬 
 177  Methylprednisolone mylan générique  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 66 💬 
 178  Methylprednisolone or budesonide  Budesonide  [7] D00246, D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 96 💬 
 179  Methylprednisolone or prednisolone  Methylprednisolone  [14] D00407, D00472, D00751, D00979, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 65 💬 
 180  Methylprednisolone po  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 13 💬 
 181  Methylprednisolone pulse  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [2] 66, 220 💬 
 182  Methylprednisolone sodium hemisuccinate  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [2] 13, 97 💬 
 183  Methylprednisolone sodium succinate  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [6] 13, 46, 49, 50, 51, 211 💬 
 184  Methylprednisolone(intravenously in the 1st-2nd-3rd month )  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 66 💬 
 185  Methylprednisolone(intravenously in the 1st-3rd-5th month)  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 66 💬 
 186  Mmf and dexamethasone  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 222 💬 
 187  Nomegestrol acetate  Acetate  [2] D07222, D08281 💬  [1] PGR 💬  [4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation  [1] 13 💬 
 188  Octreotide  Octreotide  [2] D00442, D06495 💬  [1] SSTR2 💬  [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway  [7] 67, 75, 84, 85, 89, 193, 227 💬 
 189  Octreotide acetate  Acetate  [2] D00442, D06495 💬  [1] SSTR2 💬  [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway  [1] 227 💬 
 190  Octreotide lar  Octreotide  [2] D00442, D06495 💬  [1] SSTR2 💬  [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway  [2] 67, 227 💬 
 191  Octreotide lar / sandostatin lar (lar=long acting release)  Octreotide  [2] D00442, D06495 💬  [1] SSTR2 💬  [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway  [1] 84 💬 
 192  Octreotide-lar  Octreotide  [2] D00442, D06495 💬  [1] SSTR2 💬  [4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway  [1] 67 💬 
 193  Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone  Mesalazine  [7] D00377, D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 97 💬 
 194  Oral methylprednisolone 625 mg/24h x3 days  Methylprednisolone  [6] D00407, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 13 💬 
 195  Oral prednisolone  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [2] 49, 145 💬 
 196  Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg  Estradiol  [10] D00105, D00554, D01413, D01617, D01953, D04061, D04063, D04064, D04065, D05209 💬  [3] ESR1, ESR2, PGR 💬  [11] Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway  [1] 299 💬 
 197  Overencapsulated prednisolone tablets  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 198  Paroxetine & prednisolone  Paroxetine  [12] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬  [2] NR3C1, SLC6A4 💬  [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle  [1] 46 💬 
 199  Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp  Paroxetine  [12] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬  [2] NR3C1, SLC6A4 💬  [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle  [1] 46 💬 
 200  Paroxetine hydrochloride tablets 10 & 20 mg and prednisolone 1 mg bp  Paroxetine  [12] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02260, D02362, D03301, D05374, D05375 💬  [2] NR3C1, SLC6A4 💬  [3] Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle  [1] 46 💬 
 201  Peg-liposomal prednisolone sodium phosphate  Phosphate ion  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [2] 13, 97 💬 
 202  Peginesatide  Peginesatide  [2] D09946, D09947 💬  [1] EPOR 💬  [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer  [1] 283 💬 
 203  Peri-neural dexamethasone 1 mg  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 204  Phosphate and betamethasone acetate, 2 ml.  Acetate  [7] D00244, D00972, D01357, D01402, D01637, D02032, D02286 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 235 💬 
 205  Plovamer acetate  Acetate  -  -  -  [1] 13 💬 
 206  Plovamer acetate 0.5 milligram (mg)  Acetate  -  -  -  [1] 13 💬 
 207  Plovamer acetate 10 mg  Acetate  -  -  -  [1] 13 💬 
 208  Plovamer acetate 20 mg  Acetate  -  -  -  [1] 13 💬 
 209  Plovamer acetate 3 mg  Acetate  -  -  -  [1] 13 💬 
 210  Pomalidomide and dexamethasone  Dexamethasone  [10] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592, D08976 💬  [3] IL6, NR3C1, TNF 💬  [79] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway  [1] 28 💬 
 211  Prednisolone  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 
 212  Prednisolone & dipyridamole  Dipyridamole  [9] D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [3] NR3C1, PDE4A, PDE5A 💬  [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 46 💬 
 213  Prednisolone + mabthera  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 61 💬 
 214  Prednisolone 1mg tablets  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 215  Prednisolone 2,5 mg tablets  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 216  Prednisolone 20 mg  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 217  Prednisolone 40 mg  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 218  Prednisolone 5 mg  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [2] 46, 51 💬 
 219  Prednisolone 5 mg jenapharm  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 41 💬 
 220  Prednisolone 5 mg tablets  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 221  Prednisolone 5mg gastro-resistant tablets  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 51 💬 
 222  Prednisolone 5mg tablet  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 81 💬 
 223  Prednisolone acetate  Acetate  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 222 💬 
 224  Prednisolone and chlorambucil  Chlorambucil  [9] D00266, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 222 💬 
 225  Prednisolone and mycophenolate mofetil  Mycophenolate mofetil  [12] D00472, D00752, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D05094, D05095, D05096 💬  [3] IMPDH1, IMPDH2, NR3C1 💬  [4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism  [1] 222 💬 
 226  Prednisolone and taper  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 51 💬 
 227  Prednisolone labesfal  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 228  Prednisolone sodium metasulphobenzoate  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 97 💬 
 229  Prednisolone sodium phosphate  Phosphate ion  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [2] 13, 97 💬 
 230  Prednisolone sodium succinate  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 95 💬 
 231  Prednisolone tablets b.p. 5mg  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 97 💬 
 232  Prednisolone tablets bp  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 233  Prednisolone tablets bp 1 mg  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 234  Prednisolone tablets usp 5 mg  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 235  Prednisolone-dipyridamole  Dipyridamole  [9] D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [3] NR3C1, PDE4A, PDE5A 💬  [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 46 💬 
 236  Prednisolone/prednisone  Prednisolone  [9] D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 49 💬 
 237  Prednisone (and methylprednisolone)  Methylprednisolone  [7] D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 43 💬 
 238  Prednisone acetate  Acetate  [2] D00473, D08416 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [3] 40, 49, 224 💬 
 239  Prednisone acetate tablets  Acetate  [2] D00473, D08416 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 224 💬 
 240  Prednisone or prednisolone  Prednisolone  [9] D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 66 💬 
 241  Prednisone, methylprednisolone,cyclophosphamides  Methylprednisolone  [7] D00407, D00473, D00751, D00979, D05000, D05001, D05002 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [3] 42, 43, 45 💬 
 242  Prednisone/prednisolone  Prednisolone  [9] D00472, D00473, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 35 💬 
 243  Procedure: epidural steroid (dexamethasone) injection  Dexamethasone  [9] D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 70 💬 
 244  Procedure: warm compress prior to injection of glatiramer acetate  Acetate  [1] D04318 💬  [20] HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬  [32] Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis  [1] 13 💬 
 245  Pyridoxine plus prednisolone  Prednisolone  [10] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02179, D03301, D08454 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 145 💬 
 246  Sodium acetate  Acetate  [1] D01779 💬  -  -  [1] 81 💬 
 247  Sodium-[o-[(2,6-dichlorophenyl)-amino]- phenyl]-acetate  Acetate  -  -  -  [1] 46 💬 
 248  Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate  Acetate  -  -  -  [1] 46 💬 
 249  Soluble prednisolone tablets  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 145 💬 
 250  Sotrastaurin (inn) acetate  Acetate  [1] D09671 💬  [4] PRKCD, PRKCE, PRKCH, PRKCQ 💬  [28] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Aldosterone synthesis and secretion, Apelin signaling pathway, Autophagy - animal, C-type lectin receptor signaling pathway, Chemokine signaling pathway, Diabetic cardiomyopathy, Estrogen signaling pathway, Fc gamma R-mediated phagocytosis, GnRH signaling pathway, Inflammatory mediator regulation of TRP channels, Insulin resistance, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Prion disease, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cGMP-PKG signaling pathway  [1] 97 💬 
 251  Sulphasalazine + hydroxychloroquine or prednisolone  Hydroxychloroquine  [9] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301, D08050 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 252  Tesamorelin  Tesamorelin  [2] D06655, D09015 💬  [1] GHRHR 💬  [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction  [2] 78, 265 💬 
 253  Tesamorelin (egrifta)  Tesamorelin  [2] D06655, D09015 💬  [1] GHRHR 💬  [2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction  [1] 265 💬 
 254  Tetracosactide acetate  Acetate  [1] D00284 💬  [1] MC2R 💬  [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway  [2] 83, 145 💬 
 255  Theophylline  Theophylline  [5] D00371, D01712, D02017, D06103, D06104 💬  [19] ADORA1, ADORA2A, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬  [24] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [2] 236, 299 💬 
 256  Theophylline er  Theophylline  [5] D00371, D01712, D02017, D06103, D06104 💬  [19] ADORA1, ADORA2A, ADORA2B, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬  [24] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 236 💬 
 257  Tocopherol acetate  Acetate  [1] D02332 💬  -  -  [1] 49 💬 
 258  Tocopheryl acetate  Acetate  -  -  -  [1] 206 💬 
 259  Trexan+salazopyrin+oxiklorin+prednisolone  Prednisolone  [8] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [1] NR3C1 💬  [1] Neuroactive ligand-receptor interaction  [1] 46 💬 
 260  Trexan+salazopyrin+oxiklorin+prednisolone + infliximab  Infliximab  [9] D00472, D00980, D00981, D00982, D01239, D01998, D02156, D02598, D03301 💬  [2] NR3C1, TNF 💬  [66] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway  [1] 46 💬 
 261  Triptorelin acetate and gonadorelin acetate  Acetate  [5] D00988, D03267, D04361, D06247, D08027 💬  [1] GNRHR 💬  [2] GnRH signaling pathway, Neuroactive ligand-receptor interaction  [1] 76 💬 
 262  Ulipristal acetate  Acetate  [1] D09567 💬  [1] PGR 💬  [4] Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation  [1] 10 💬 
 263  Z102 (prednisolone and dipyridamole).  Dipyridamole  [9] D00302, D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301 💬  [3] NR3C1, PDE4A, PDE5A 💬  [7] Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway  [1] 46 💬 
 264  Zinc acetate  Acetate  [1] D06408 💬  -  -  [2] 171, 299 💬 
 265  Zinc acetate (20mg/d)  Acetate  [1] D06408 💬  -  -  [1] 299 💬 
 266  Zinc acetate dihydrate  Acetate  [1] D06408 💬  -  -  [1] 171 💬 
 267  Zuretinol acetate  Acetate  -  -  -  [1] 90 💬 

Back to top